ArticleClinical ophthalmology (Auckland, N.Z.)2021

ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema.

Laurent Kodjikian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.